Debrisoquin,
Debrisoquine,
Tendor,
DEBRISOQUIN SULFATE,
581-88-4,
Declinax,
Tendor,
Isocaramidine sulfate,
Pasiron-T,
Debrisoquine sulfate,
Equitonil,
Debrisoquine sulphate,
Debrisoquin sulfate [USAN],
Debrisoquin hemisulfate,
UNII-Q94064N9NW,
EINECS 209-472-4,
NSC 139330,
Q94064N9NW,
Ro 5-3307/1,
2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-, sulfate (2:1),
1,2,3,4-Tetrahydro-isoquinoline-2-carboxamidine sulfate,
Debrisoquin sulfate (USAN),
DSSTox_CID_27755,
DSSTox_RID_82532,
DSSTox_GSID_47775,
3,4-Dihydro-2(1H)-isoquinolinecarboxamidine sulfate (2:1),
3,4-Dihydro-2(1H)-Isoquinolinecarboximidamide Sulfate (2:1),
CHEBI:50973,
C10H13N3,
NCGC00016513-01,
CAS-581-88-4,
3,4-dihydro-1H-isoquinoline-2-carboximidamide;sulfuric acid,
Declinax (TN),
Prestwick_690,
2(1H)-Isoquinolinecarboxamidine, 3,4-dihydro-, sulfate (2:1),
3,4-dihydro-1H-isoquinoline-2-carboximidamide; sulfuric acid,
Debrisoquin Sulfate,
AC1L1X9D,
SCHEMBL122316,
bis(debrisoquin); sulfuric acid,
CHEMBL1593558,
DTXSID2047775,
AOB5331,
HMS1569K05,
HMS2096K05,
HMS3713K05,
Tox21_110468,
MFCD00153791,
AKOS026751495,
Tox21_110468_1,
API0002230,
CCG-220372,
Ro-533071,
NCGC00016513-05,
Ro 5-33071,
AS-16854,
LS-85430,
FT-0665523,
D03664,
SR-01000872657,
SR-01000872657-1,
3,4-Dihydro-2(1H)-isoquinolinecarboxamide hemisulfate,
3,4-dihydroisoquinoline-2(1H)-carboximidamide hemisulfate,
DEBRISOQUINSULFATE,
CID11391,
C10H13N3.1/2H2O4S,
C10-H13-N3.1/2H2-O4-S,
3,4-dihydro-1H-isoquinoline-2-carboximidamide,
3,4-Dihydro-2(1H)-isoquinolinecarboximidamide,